A recent study from USC Leonard Davis School of Gerontology reveals that adherence to a Mediterranean diet may enhance levels of mitochondrial microproteins humanin and SHMOOSE, which are associated with cardiovascular and brain health. The findings suggest that specific dietary…
The World Health Organization has released updated guidelines indicating that up to 45% of dementia cases could be delayed or prevented by addressing modifiable risk factors. Thes…
Recent viral claims suggest that statins, commonly prescribed cholesterol-lowering medications, may contribute to dementia. However, scientific evidence reviewed by DW Fact Check…
The World Health Organization has introduced updated guidelines aimed at reducing the risk of cognitive decline and dementia, suggesting that up to 45% of dementia cases could be…
A new study published in Nature investigates the effects of the ketogenic diet on intestinal cancer in mice, revealing that it can accelerate tumor growth in the small intestine w…
A recent study indicates that early-onset dementia may begin affecting work productivity and income up to 15 years before a formal diagnosis. Researchers tracked 793 individuals d…
A recent study led by USC involving over 214,000 older adults across 14 countries highlights significant variations in dementia risk factors, suggesting that prevention strategies…
A recent study indicates that even minor heart issues may predict tissue deterioration in brain regions associated with Alzheimer's disease. Researchers found that subtle cardiac…
Recent studies have revealed significant findings about vitamin D's impact on various health aspects, including cognitive health, depression risk, and even height. These findings…
A new regimen for anti-aging medications now includes a daily dose of rapamycin alongside weekly self-affirmations and monthly spa visits to maintain optimal brain health and fend…
Prabha Jha, a leader at Verizon, leveraged her experience in MIT's AI for Senior Executives program to co-write 'The AI Anthology,' a collection of insights on AI's impact across…
Anavex Life Sciences is making strides in its Phase 3 planning for Alzheimer's disease with the FDA, having submitted clinical trial data and reporting a cash position of $118.3 m…